Life Sciences Partner
CincyTechCheck size: The firm does not publish a person-specific check-size range on its current official website.
Kenneth Morand, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
The firm publicly emphasizes partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
No person-specific pass list is public. Opportunities outside the firm's published stage, sector, geography, or traction criteria appear less aligned.
Lead with founder-market fit, customer evidence, traction, the financing plan, and a precise explanation of alignment with the firm's published strategy.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Kenneth Morand, Ph.D. is Life Sciences Partner at CincyTech, according to the firm's current official roster. To avoid mistaken identity, no unsupported prior employment, education, or portfolio attribution has been inferred.